Clinical Trial

Health Outcomes in Cisgender Men and Transgender Women

Study Description

Improving Health Outcomes in Young Cisgender Men and Transgender Women (mLab App)

The mLab App combines HIV prevention information with push notifications/reminders to complete HIV testing and an automated image processing feature to provide real-time feedback on home-based HIV test results. Theoretically-guided by the Health Information Technology Usability Evaluation Model (Health-ITUEM), the proposed project will refine and test a next-generation diagnostic intervention delivered on a mobile platform to improve HIV testing and linkage-to-care outcomes among youth living with and at-risk for HIV. Given the pervasiveness, low cost, and convenience of mobile technology, the investigators hope that the App can help achieve the goals of the National HIV/AIDS Strategy in the US by increasing the number of persons living with HIV who know their serostatus, decreasing HIV-related disparities, and ultimately reducing the risk of HIV transmission and acquisition.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - mLab App

The mLab App is a web application that uses an image processing algorithm to interpret the results of the OraQuick® In-Home HIV Test.

Behavioral - HIV Prevention Information

Youth randomized to the standard of care will be sent an email with links to mobile-optimized online prevention information, including PrEP and HIV testing information that is found on the Centers for Disease Control and Prevention (CDC) website.

Device - HIV Home Tests

Youth randomized into this arm will receive OraQuick® In-Home HIV Test.

Additional Information

Official Study Title

mLab App for Improving Uptake of Rapid HIV Self-testing and Linking Youth to Care

Clinical Trial ID

NCT03803683

ParticipAid ID

dBBOnd